Mylab partners with Ekincare to promote SII’s NASOVAC-S4 among corporates The joint effort between Mylab and Ekincare will enable businesses to incorporate NASOVAC-S4 into their employee wellness programs
Development of universal influenza vaccines gaining precedence: Study The current influenza vaccines only provide protection against a limited number of strains
US HHS funds development of needle-free vaccine administration technology Phase 1 clinical trial, expected to start in 2022, to include more than 400 adult volunteers using unadjuvanted and adjuvanted…
